[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Orgenesis Inc (ORGS)

Orgenesis Inc (ORGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 2,068
  • Shares Outstanding, K 5,169
  • Annual Sales, $ 1,040 K
  • Annual Income, $ -48,170 K
  • EBIT $ -29 M
  • EBITDA $ -27 M
  • 60-Month Beta 3.14
  • Price/Sales 10.59
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -11.51
  • Most Recent Earnings $-4.38 on 03/26/26
  • Next Earnings Date 12/31/25
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0010 +39,900.00%
on 07/16/26
0.4500 -11.11%
on 07/13/26
-0.0950 (-19.19%)
since 06/23/26
3-Month
0.0010 +39,900.00%
on 07/16/26
0.8450 -52.66%
on 05/13/26
+0.2900 (+263.64%)
since 04/23/26
52-Week
0.0001 +99,999.99%
on 07/29/25
1.0000 -60.00%
on 10/16/25
-0.6000 (-60.00%)
since 07/23/25

Most Recent Stories

More News
Tri Pointe: Q2 Earnings Snapshot

Tri Pointe: Q2 Earnings Snapshot

ORGS : 0.4000 (unch)
Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies

Strategic Acquisition Designed to Expand Access to Cost-Effective, Scalable Regenerative Medicine Treatments

ORGS : 0.4000 (unch)
Orgenesis Secures Up to $5 Million Equity Investment from Williamsburg Venture Holdings

Funding Aimed at Accelerating Rollout of Decentralized CGT Platform

ORGS : 0.4000 (unch)
Orgenesis Provides Third Quarter 2024 Business Update

ORGS : 0.4000 (unch)
Orgenesis Commences Trading on OTCQX® Best Market

ORGS : 0.4000 (unch)
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021

LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be...

VMAR : 0.7290 (-12.42%)
FLGC : 8.95 (-18.41%)
VIRI : 0.1550 (+12.40%)
ZIVO : 5.0000 (+25.00%)
FAU.AX : 0.007 (unch)
GBLX : 0.0003 (unch)
VEV : 0.0201 (-58.30%)
TBRD.VN : 1.710 (+2.40%)
XXII : 4.27 (-8.17%)
GOVX : 0.7312 (-12.95%)
OSS.VN : 0.870 (unch)
RCRT : 2.74 (+7.03%)
Orgenesis to Present at the SNN Network Summer Virtual Event on Thursday, August 19, 2021

GERMANTOWN, MD / ACCESSWIRE / August 12, 2021 / Orgenesis Inc. (NASDAQ:ORGS), a global biotech company working to unlock the full potential of cell and gene therapies, today announced that it will be presenting...

ORGS : 0.4000 (unch)

Business Summary

Orgenesis, Inc. is a biopharmaceutical company. It focused on developing its trans-differentiation technologies for diabetes. The company deals with the combination of cell-based therapy and regenerative medicine into clinical development. Its operating segment consists of Contract Development and Manufacturing...

See More

Key Turning Points

3rd Resistance Point 0.8800
2nd Resistance Point 0.6400
1st Resistance Point 0.5200
Last Price 0.4000
1st Support Level 0.1600
2nd Support Level N/A
3rd Support Level N/A

See More

52-Week High 1.0000
Fibonacci 61.8% 0.6180
Fibonacci 50% 0.5001
Last Price 0.4000
Fibonacci 38.2% 0.3821
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.